PATENT CLAIM ANALYSIS

Application Number: 16068558
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "291000"]

Abstract:
The present invention provides tacrolimus for use in the treatment in a human subject of a TDP-43 proteinopathy, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementias (FTDs), wherein the tacrolimus is for administration at a therapeutically-effective dose which does not cause immunosuppression in the subject.

Claim (Index 6):
The method of  claim 1 , wherein the tacrolimus is administered a daily dose not exceeding 0.020 mg/kg.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.29268
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15370032', '14742164', '14398379', '14935024', '14354404']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7614987039961887
- 35 USC 102 Novelty (BERT): 0.516263154708915
- Combined Prediction Score: 0.7369751490674613
- Mean Citation Score: 236.962136
- Max Citation Score: 248.97473
- Similarity Product: 143.47093547514675

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test